Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide DNA methylation profiling reveals candidate biomarkers and probable molecular mechanism in metabolic syndrome [array]

ABSTRACT: Genome-wide DNA methylation profiling reveals candidate biomarkers and probable molecular mechanism in metabolic syndrome [array]

PROVIDER: PRJNA752149 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome

Project description:Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome

| PRJNA752797 | ENA

Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome [RNA-seq]

Project description:Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome [RNA-seq]

| PRJNA752799 | ENA

Genome-wide DNA methylation profiling reveals candidate biomarkers and probable molecular mechanism in metabolic syndrome [array]

Project description:The goals of this study are to investigate the molecular mechanism and biomarker by DNA methylation profiles in patients with metabolic syndrome compared to normal.

2022-05-04 | GSE181485 | GEO

Genome-wide DNA methylation profiling reveals candidate biomarkers and probable molecular mechanism of metabolic syndrome.

Project description: Not available

| S-EPMC9170599 | biostudies-literature

Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-05-04 | GSE181647 | GEO

Genome-wide DNA methylation proifling reveals candidate biomarkers and probable molecular mechanisms in metabolic syndrome [RNA-seq]

Project description:The goals of this study are to investigate the molecular mechanism and biomarker by DNA methylation profiles in patients with metabolic syndrome compared to normal.

2022-05-04 | GSE181646 | GEO

TLDA miRNA Screen for Candidate AD Biomarkers in CSF from Living Donors

Project description:Identify candidate miRNA biomarkers for AD in CSF.

2022-09-03 | GSE212558 | GEO

Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy.

Project description:PurposeTo investigate the molecular mechanism and search for candidate biomarkers in the gene expression profile of patients with diabetic peripheral neuropathy (DPN).MethodsDifferentially expressed genes (DEGs) of progressive vs non-progressive DPN patients in dataset GSE24290 were screened. Functional enrichment analysis was conducted, and hub genes were extracted from the protein-protein interaction network. The expression level of hub genes in serum samples in another dataset GSE95849 was obtained, followed by the ROC curve analysis.ResultsA total of 352 DEGs were obtained from dataset GSE24290. They were involved in 14 gene ontology terms and 10 Kyoto Encyclopedia of Genes and Genomes pathways, mainly related to lipid metabolism. Eight hub genes (LEP, APOE, ADIPOQ, FABP4, CD36, GPAM, CIDEC, and PNPLA4) were revealed, and their expression level was obtained in dataset GSE95849. The receiver operating characteristic curve analysis indicated that CIDEC (AUC=1), APOE (AUC=0.833), CD36 (AUC=0.803), and PNPLA4 (AUC=0.861) might be candidate serum biomarkers of DPN.ConclusionLipid metabolism of Schwann cells might be inhibited in progressive DPN. CIDEC, APOE, CD36, and PNPLA4 might be potential predictive biomarkers in the early DPN diagnosis of patients with DM.

| S-EPMC6662509 | biostudies-literature

Circulating MicroRNAs as Biomarkers of Metabolic Syndrome

Project description:Metabolic syndrome is a common and complicated metabolic disorder and defined as a clustering of metabolic risk factors such as insulin resistance or diabetes, obesity, hypertension, and hyperlipidemia. The identification of accurate and effective biomarkers is beneficial to the early diagnosis and treatment of metabolic syndrome. Our study firstly detected the plasma miRNA expression profile of MetS patients compared with control group by high-throughput sequencing and integrated bioinformatics approaches. To our best knowledge, our study firstly perform high-throughput sequencing to obtain the circulating microRNA expression data in MetS plasma, and identified several potential plasma biomarkers for MetS.

2023-07-24 | GSE155096 | GEO

Circulating MicroRNAs as Biomarkers of Metabolic Syndrome

Project description:Circulating MicroRNAs as Biomarkers of Metabolic Syndrome

| PRJNA648409 | ENA